NCICBR26_2A: NCICBR26, figure 2A

NCICBR26_2AR Documentation

NCICBR26, figure 2A

Description

Kaplan-Meier digitized data from NCICBR26, figure 2A (PMID 25439692). A reported sample size of 720 for a primary endpoint of OS in lung cancer.

Usage

NCICBR26_2A

Format

A data frame of 720 observations and 3 variables:

time event time (in months)
event OS event indicator (0: no event, 1: event)
arm treatment arms (dacomitinib, placebo)

Source

Ellis PM, Shepherd FA, Millward M, et al. Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial. Lancet Oncol 2014; 15: 1379–88.

Examples

summary(NCICBR26_2A)

kmplot(NCICBR26_2A)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.